StockNews.com assumed coverage on shares of Aptevo Therapeutics (NASDAQ:APVO – Free Report) in a research report sent to investors on Saturday morning. The firm issued a hold rating on the biotechnology company’s stock. Separately, Alliance Global Partners began coverage on shares of Aptevo Therapeutics in a research note on Monday, October 9th. They issued a […]